DIAGNOSTICS
KEYWORDS: heart, failure, heart failure, risk, cardiac, patients, troponin, blood, coronary, biomarkers, assays, disease, myocardial, cvd, used

groups.114 Like the ASCVD tool, it does not incorporate other known risk factors for CVD, as outlined in Table 6-1.114 Table 6-1. Comparison of Factors Used in Four Cardiovascular Disease Risk Stratification Tools111,114-5,118-9 FRAMINGHAM REYNOLDS ASCVD SCORE 2008 RISK SCORE Age     Sex     Race * Cholesterol ‡  §  Blood pressure ‡  ‡  Blood pressure treated   with medication Smoking status     Diabetes   BMI § Country/Region † Aspirin use  hsCRP  Parental history of MI  BMI – body mass index; hsCRP – high-sensitivity C-reactive protein; MI – myocardial infarction * Only African American and White † Differentiates between high- and low-risk countries in Europe § Framingham uses either cholesterol or BMI ‡ Incorporates treated and untreated LEARNING GUIDE: CARDIAC 56 Framingham General CVD Risk Tool The Framingham General CVD Risk Tool (sometimes known as Framingham 2008) was developed to predict the 10-year risk of CVD. It was a modification of an earlier tool, the Framingham risk assessment, which calculated risk for coronary heart disease. The Framingham General CVD tool broadened this focus to predict CVD risk, which included cerebrovascular events (such as
